BE Study of the Combinations of Gemigliptin 50mg and Metformin HCl Extended Release 2000mg in Comparison to Each Component Administered Alone

Launched by LG LIFE SCIENCES · Jan 29, 2016

Keywords

ClinConnect Summary

No description provided

Gender

MALE

Eligibility criteria

• Inclusion Criteria:
• • Age between 19 to 45, healthy male subjects(at screening)
• • Body weight between 55kg - 90kg, BMI between 18.0 - 27.0
• • FPG 70-125mg/dL glucose level(at screening)
• • Subject who totally understand the progress of this clinical trials, make decision by his free will, and signed a consent form to follow the progress.
• Exclusion Criteria:
• • Subject who has past or present history of any diseases following below.(liver including hepatitis virus carrier, kidney, Neurology,immunology,pulmonary,endocrine,hematooncology,cardiology,mental disorder.)
• • Subject who had GI tract disease or(ulcer, acute or chronic pancreatitis) surgery.(appendectomy, hernioplasty are not included)
• • Subject who had drug hypersensitivity reaction.(Aspirin, antibiotics)
• • Subject who already participated in other trials in 3months
• • Subject who had whole blood donation in 2months, or component blood donation in 1months or transfusion in 1months currently.
• • Smokers.(but, if the subject did'nt smoke in 3months, can participate the trial)